Atlas Trials

The Drug-Drug Interaction of SHR4640 and Febuxostat in Patients With Hyperuricemia

Clinical trial NCT04157959 · UNKNOWN

Trial details

NCT number
NCT04157959
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Hyperuricemia
Start date
2019-10-14
Primary completion
2020-06-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.